275) Risk and protective factors for initiation |
276) f frontal EEG alpha asymmetry in ASD high-risk and low-risk infant populations. |
277) to expand, this undifferentiated minimal risk and burden requirement does not suffi |
278) is to allow for exceptions to the minimal risk and burden requirement in cases of ex |
279) Essential information about the risk and danger of thalassemia was given t |
280) identified between increasing nutritional risk and decreased retention in treatment. |
281) ncers and might be associated with cancer risk and disease outcome. |
282) A (mtDNA) might be associated with cancer risk and disease outcome. |
283) the association between childhood cancer risk and distance from the home address at |
284) reoperative diagnosis can anticipate this risk and harvest a fascio-cutaneous flap c |
285) e categorised into two groups as low fall risk and high fall risk with 13.5 s durati |
286) more suitable for evaluating the overall risk and long-term prognosis. |
287) of health professionals of the potential risk and management of swallowing dentures |
288) h research unless it entails only minimal risk and minimal burden. |
289) he subgroup analysis, no increased sepsis risk and mortality risk were found in cauc |
290) tion of factor V Leiden (FVL) with sepsis risk and mortality risk. |
291) language scores at 18 months in both low risk and non-diagnosed high risk infants. |
292) ulated reward; each pump presents greater risk and potential reward (represented by |
293) ontrolled trial, the universal effects on risk and protective factors were observed. |
294) ed for boys and girls once accounting for risk and protective factors. |
295) Aside from studies based on risk and resilience, there has been little |
296) of inflammation correlated with increased risk and severity of various diseases. |
297) ion by pump number when participants took risk, and to overall earnings. |
298) ked to poor decision-making and increased risk-taking. |
299) which must therefore be deemed an area at risk. |
300) erstanding of the factors involved in HIV risk. |
301) modelled separately for each component of risk. |
302) nificantly associated with bladder cancer risk. |
303) heir use as predictive biomarkers for MFH risk. |
304) mportant in determining long term obesity risk. |
305) -outs may have a different cardiovascular risk. |
306) Poverty represents a considerable health risk. |
307) genotyping information and breast cancer risk. |
|